We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Presents AI-Driven Diagnostic Innovation and Advanced Alzheimer's Disease Blood Testing Solutions

By LabMedica International staff writers
Posted on 18 Nov 2025

Fapon, a global leader in life sciences, is participating at MEDICA 2025 from November 17 to 20 in Düsseldorf, Germany, where it is underscoring its strengths in diagnostic innovation. More...

At booth A81 in Hall 3, the company is presenting how AI-driven technologies are advancing diagnostic R&D and unveiling a range of IVD solutions and new products, with particular emphasis on its state-of-the-art blood testing solutions for Alzheimer’s disease (AD).

Fapon’s “AI-driven + closed-loop dry and wet experimentation” R&D model greatly enhances the efficiency of biomarker discovery and the development of diagnostic solutions. A standout achievement of this approach is the company’s advanced AD blood testing solution. Designed to support IVD manufacturers, it offers a complete suite of raw materials and bulk reagents for core Alzheimer’s biomarkers, including p-tau 217, p-tau 181, amyloid beta 40, amyloid beta 42, GFAP, NfL, and APOE4. These innovative materials deliver high sensitivity and specificity, with strong concordance to predicate kits and established clinical tests, enabling the development of more precise and reliable AD assays.

Fapon is also presenting its full suite of one-stop IVD solutions, encompassing raw materials, reagent development services, and open-platform instruments. A highlight is the chemiluminescence one-stop solution, which integrates high-performance core materials, a panel of more than 70 self-developed assays, and the versatile Shine i-Series CLIA analyzers encompassing low to ultra-high throughput to address testing demands across diverse clinical settings. Additionally, the Shine mT8000 Fully Automatic Clinical Chemistry and Immunoassay System provides end-to-end workflow automation within a compact, space-efficient footprint of just 5 m².

Fapon is also showcasing its portfolio of high-performance IVD raw materials, including recombinant quality-control and calibrator components for key disease markers such as RF, HbA1c, HIV/HIV-P24, HCV, TP, HBV, and ToRCH. The company is further highlighting its animal-origin-free IgG blockers and LAMP solutions designed for rapid molecular testing.

Related Links:
Fapon Biotech


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Multi-Chamber Washer-Disinfector
WD 390
New
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.